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PENETAPAN SISTEM MAKLUMAT UBAT FARMASEUTIKAL HALAL: 
KONSEP, SUMBER DAN, POTENSI DALAM INDUSTRI 
 
ABSTRAK 
Bahan bahan farmaseutikal yang dikilangkan atau dihasilkan terdiri daripada sumber 
dan asal-usul yang berbeza, samada bahan kimia, mineral, tumbuh-tumbuhan, 
haiwan, bioteknologi atau imunologi. Pengguna Muslim di seluruh dunia 
menggunakan undang-undang halal, yang merupakan sebahagian daripada Syariah 
atau undang-undang Islam.  Dalam bahasa Arab, halal bermaksud mematuhi undang-
undang atau yang dibenarkan, yang tidak hanya digunakan bagi makanan, malahan 
juga mencakupi kesemua aspek hidup yang lain. Farmaseutikal halal adalah ubat 
yang mengandungi bahan kandungan yang dibenarkan dan dihasilkan berdasarkan 
aturan dan undang-undang halal. Pengesahan dan pengauditan halal adalah satu 
sistem pengurusan kualiti untuk memastikan status halal bagi sesuatu produk tertentu 
melalui konsep “Quality built-in rather than tested for.” Standard atau piawaian 
tertentu sepatutnya dipatuhi semasa rantaian bekalan, iaitu penyumberan, 
pengeluaran / pengilangan, pengangkutan dan pemasaran.  Ia termasuk bahan 
mentah, pengilangan / pembuatan, pembungkusan, penyimpanan, agihan dan 
pendispensan. Walaupun terdapat peningkatan kesedaran tentang farmaseutikal halal 
dalam kalangan pengguna dan pihak berkuasa, namun tiada rujukan berdasarkan 
bukti yang menyediakan maklumat tentang status halal farmaseutikal, standard, 
prosedur operasi standard (standard operating procedures, SOP), dan garis panduan 
untuk memastikan bahawa pihak pengeluar mematuhi undang-undangf halal. Kajian 
ini bermatlamat menonjolkan semua isu berkaitan dengan farmaseutikal halal melalui 
penggunaan kaedah dan peralatan perkhidmatan maklumat ubat. Sorotan literatur 
secara sistematik dijalankan untuk memastikan aspek yang relevan tentang 
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farmaseutikal halal (definisi, pensijilan, standard, pengauditan, pemasaran, 
pendidikan, latihan dan undang-undang Islam). Prinsip perkhidmatan maklumat ubat 
digunakan untuk menganalisis soalan berhubung dengan isu farmaseutikal halal, 
sumber maklumat diperoleh, menilai data, dan merumus jawapan dalam format 
persembahan yang sesuai. Kajian ini memperkenal serta menetapkan garis panduan 
bagi menjawab kemusykilan baru yang mungkin dihadapi oleh pakar maklumat ubat, 
yang bertanyakan status halal bagi farmaseutikal tertentu dan asal-usul mereka. Tesis 
ini juga mendidik undang-undang Islam tentang farmaseutikal halal dan menetapkan 
aturan untuk mencari, menempatkan dan melaporkan jawapan daripada sumber fiqah 
yang berbeza. Maklumat yang terkumpul digunakan untuk mencadangkan satu pelan 
penulisan bagi farmakopoeia halal. Satu monograf model, yang dikenali juga sebagai 
farmakopoeia halal dicadangkan berdasarkan analisis kritikal daripada bahan 
kandungan sediaan terpilih. Satu tinjauan menggunakan soal selidik yang diolah dan 
pertemuan kumpulan pakar dijalankan untuk mencadangkan satu model primitif 
tentang SOP farmaseutikal halal. SOP yang dicadangkan dan farmakopoeia 
berpotensi digunakan dalam industri bagi membantu syarikat di seluruh dunia 
memahami tentang amalan farmaseutikal halal, cara mengamalkannya semasa 
penghasilan farmaseutikal, dan cara untuk membangunkan jawatankuasa dan 
pasukan halal mereka sendiri. 
 
 
 
 
 
 
 xx 
 
ESTABLISHING HALAL PHARMACEUTICALS INFORMATION 
SYSTEMS: CONCEPTS, SOURCES AND, POTENTIALS IN THE 
INDUSTRY 
 
ABSTRACT 
Pharmaceuticals are manufactured from different sources and origins; chemicals, 
minerals, plants, animals, biotechnologicals and immunologicals. Muslim consumers 
around the world subscribe to the halal pharmaceuticals, which is a part of Shariah or 
islamic law. Halal is an Arabic word for the lawful or permitted, usually used for 
food but also covers all aspects of life. Halal pharmaceuticals are drugs that contain 
permissible ingredients and are produced according to the rules and conditions of 
halal pharmaceuticals. Halal certification and auditing is a quality management 
system to ensure the halal status of a certain product via the concept “Quality built-in 
rather than tested for.” Certain standards should be adhered to throughout the supply 
chain namely sourcing, production, transporting and marketing. These include; raw 
materials, manufacturing, quality control, packaging, storing, distributing and 
dispensing. Even though there is enhanced awareness regarding halal 
pharmaceuticals among the consumers and authorities, hitherto there is no evidence-
based reference that provides information on the halal status of pharmaceutical 
standards, standard operating procedures (SOPs) and guidelines to ensure that 
manufacturers stick to the halal pharmaceuticals. This study aims to highlight 
pertinent issues related to halal pharmaceuticals by using methods and tools of drug 
information service. A systematic literature review was made to glean relevant 
aspects of halal pharmaceuticals (definition, certification, standards, auditing, 
marketing, education, training, and islamic laws). Drug information service 
principles were used to analyze issues regarding halal pharmaceuticals, locate 
information resources, evaluate the data and formulate answers in a suitable 
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presentation format. This study has introduced and set the guidelines to answer new 
types of inquiries faced by drug information specialists; questioning the halal status 
of certain pharmaceuticals and their origin. This study also elucidated islamic law on 
halal pharmaceuticals and has set the rules to search, locate and report answers from 
different types of fiqh resources. Information compiled was then used to propose a 
writing plan for a Halal Pharmacopoeia. Model monographs of the proposed Halal 
Pharmacopoeia were designed based on critical analysis of the ingredients of selected 
preparations. A survey using a designed questionnaire and expert group meetings 
were conducted to propose a primitive model of standard operating procedures 
(SOPs) of halal pharmaceuticals. The proposed SOPs and pharmacopoeia are 
potentially useful in the industry by helping companies all over the world to 
understand the practice of halal pharmaceuticals, how to subscribe to it during 
production of pharmaceuticals and how to set up their in-house halal committees and 
teams.  
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CHAPTER ONE: INTRODUCTION AND LITERATURE REVIEW 
 
Awareness on Halal pharmaceuticals has increased in the last five years, 
though there is limited research data scientifically presented in pharmaceutical 
research journals on this subject. This limited availability of data on halal 
pharmaceuticals became the basis of starting this study.  
  
Halal concepts are among important factors to choose between different 
pharmaceuticals properties for Muslims. There are different origins of the 
pharmaceuticals and usually people consume the pharmaceuticals which agree and fit 
their religion (Simoons, 1994), safety, and health concerns. Drug information tools 
and methods can help in solving problems related to halal pharmaceuticals. The 
introduction chapter will cover the aspects of halal pharmaceuticals as in drug 
information by defining pharmaceuticals and the methods of manufacturing them.  
 
 It will also cover the aspects of pharmacy practice, systematic review of 
halal pharmaceuticals in the main databases followed by discussion on the current 
situation of halal pharmaceuticals. The objectives of the research will be established 
and the contribution of this study will also be highlighted. 
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1.1 Methods 
1.1.1 Database and search strategies 
 
Literature searches were conducted in the following three electronic 
databases: Pub Med, EBSCO HOST, and Google Scholar. Literature searches were 
ended on 10th July, 2014. The following search terms were used individually or in 
combination: ‘halal’, ‘pharmaceuticals’, ‘medicine’, ‘vaccine’, ‘porcine’, ‘animal’, 
‘bovine’, and ‘natural’. Reference lists of retrieved papers were searched as well. 
 
1.1.2 Inclusion and Exclusion Criteria 
 
All books and peer reviewed articles, written in English, discussing different 
issues of halal were included. Magazine articles and conference proceedings were 
excluded as were the articles based on halal economy, halal tourism, Islamic finance, 
meat science and poultry with the exception of articles discussing food as well as 
pharmaceuticals from halal perspective.  
 
1.1.3 Data Extraction and Quality Assessment  
 
According to the predefined criteria, extracted data information included 
authors, title of article, year of publication, summary and comments and presented in 
a table format.  The tables will be followed by a short discussion to highlight some 
important terms and conclusions from the collected articles. 
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1.2 Results and Discussion (Information Report) 
 
1.2.1 Pharmaceuticals Definition and Their Method of Manufacturing  
 
Historically, people used medicines from different origins (plants, animals, 
and minerals) (The Merck Index, 2006). Pharmaceuticals are also referred to as 
medicinal products, dosage forms, or drug products (Merriam-Webster, 2004) mean: 
“any compound or preparation used for the treatment or prevention of disease. They 
are intended for human or veterinary use which is subject to control by health 
legislation in the manufacturing country or in the importing country” (PIC/S, 2013). 
Pharmaceuticals include both Active Pharmaceutical Ingredients (API) and 
excipients. API is defined as: “any substance or mixture of substances intended to be 
used in the manufacture of a drug (medicinal) product and that, when used in the 
production of a drug, becomes an active ingredient of the drug product. Such 
substances are intended to furnish pharmacological activity or cause other direct 
effects in the diagnosis, cure, mitigation, treatment, or prevention of disease or to 
affect the structure and function of the body” (PIC/S, 2013).  
 
An excipient is an inactive or inert substance that forms a vehicle, formulated 
alongside the API of a medication to serve various therapeutic, manufacturing 
process and for stability enhancing purposes (Swarbrick, 2007). Famous categories 
include: anti adherents, binders, coatings, colours, disintegrants, fillers, flavours, 
glidants, lubricants, preservatives, sorbents, and sweeteners. Pharmaceuticals can be 
obtained from many sources these days. Table 1.1 illustrates the types of API origins 
according to the PIC/S [the Pharmaceutical Inspection Convention (PIC) and the 
Pharmaceutical Inspection Co-operation Scheme (PIC Scheme)]. Blood related 
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products, cosmetics, and dietary supplements are not part of our research according 
to the previous definition. 
 
Table 1.1: Types of API manufacturing techniques, (adapted from (PIC/S, 2013) 
Types of API Manufacturing Techniques 
  
1. Chemical manufacturing  
2. API derived from animal sources  
3. API extracted from plant sources  
4. Herbal extracts used as API  
5. API consisting of comminuted or powdered herbs  
6. Biotechnology: fermentation /cell culture  
7. “Classical” fermentation to produce an API  
 
1.2.2 Halal Definition and Background 
 
Food and medicine choice normally reflects aspects of lifestyle, culture, 
religion, diet and health concerns. Every country has specific concerns and wishes to 
determine its own particular priorities for targeting authenticity issues, labelling and 
compositional regulations (Nakyinsige, Man, & Sazili, 2012). Religion is among the 
major factors determining food and medicine avoidance, taboos and special 
regulation (Simoons, 1994). 
 
Dietary laws describe and give details of food and beverages which people 
abstain from consuming because of a religious or cultural prohibition. Kashrut is the 
set of Jewish dietary laws. Food that may be consumed according to halakha (Jewish 
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law) is termed kosher in English, which means "fit" (in this context, fit for 
consumption) (Regenstein, Chaudry, & Regenstein, 2003). Diet in Hinduism is 
traditionally governed by the rules laid out in the Dharmaśāstras, a genre of Sanskrit 
texts pertaining to Hindu religious and legal duty. Buddhist cuisine is an East Asian 
cuisine which is followed by some believers of Buddhism. It is primarily vegetarian, 
a manifestation of the general Buddhist precept of ahimsa (non-violence). 
Vegetarianism is the practice of abstaining from the consumption of meat – red meat, 
poultry, seafood and the flesh of any other animal; it may also include abstention 
from by-products of animal slaughter, such as animal-derived rennet and gelatine 
(Merriam-Webster, 2004). 
 
From Muslims’ point of view, decision to choose one food over the other 
depends on its halal status. However, the Islamic dietary law is universal and derived 
from the Holy Quran, which makes it similar in all nations of the world (Nakyinsige 
et al., 2012). The term halal can describe any human activity but it is most related 
with food until now. Halal industry Development Corporation (HDC) in Malaysia 
mentioned nine major sectors in halal industries include the following ("HDC," 
2013): 
Food 
Animal feed 
Cosmetics and toiletries  
Ingredients and additives  
Biologicals and vaccines 
Pharmaceuticals 
Tourism and hotels 
Islamic finance and banking 
Logistics
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The halal dietary laws define food products as “halal” (permitted) or “haram” 
(prohibited), however, a few items have been categorize in “makrooh” “mashbooh” 
(questionable to detestable). The law deals with the following five issues; all but the 
last are in the animal kingdom (Riaz & Chaudry, 2004). 
1) Prohibited animals 
2) Prohibition of blood 
3) Method of slaughtering/blessing 
4) Prohibition of carrion 
5) Prohibition of intoxicants. 
 
The Islamic dietary laws are derived from the Quran, a revealed book; the 
Sunnah (also known as hadith), the traditions of Prophet Muhammad; and through 
extrapolation of and deduction from the Quran and the Sunnah, by Muslim jurists. 
Approximately 90% of Muslims are Sunni, while the other 10% are shia (Pulsfort, 
2010). This thesis will generally follow Sunni practice.  
 
Halal encompasses origin, species, production system, slaughter procedure, 
processing method, storage and the logistics of food or medicine. All these 
characteristics are not visible and cannot be verified by the consumer at the pre-
purchase stage (Penang, 2006). Four from the nine sectors of halal industry are 
related to Pharmaceutical sciences (Center, 2013).  
Cosmetics and toiletries  
Ingredients and additives  
Biologicals and vaccines 
Pharmaceuticals
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The regulations, awareness and production of halal pharmaceuticals are still 
in their infancy in comparison to the detailed transcription of halal status of food and 
beverage. Halal status of food or medicine is a credence attribute that cannot be 
ascertained by the consumer, even upon consumption of the food or medicine. 
Owing to the change in peoples’ lifestyle today, the food chain has become very long  
and can be described as from the farm to the table. This has resulted in the need of 
halal certifying authorities (Vandendriessche, 2008). 
 
The identity and authentication of ingredients in processed or composite 
mixtures has emanated into appointment or formation of credible halal certification 
bodies like Halal Food Authority (HFA) in UK, Islamic Food and Nutrition Council 
of America (IFANCA), Halal Food Council International (HFCI), Australian 
Federation of Islamic Council (AFIC), Federation of Islamic Association of New 
Zealand (FIANZ), Islamic Religious Council of Singapore (MUIS), Ulama Council 
of Indonesia (MUI), Central Islamic Committee of Thailand (CICT) and Department 
of Islamic Development (Jabatan Kemajuan Islam Malaysia) (JAKIM) in Malaysia. 
Crucially, such bodies should endeavour to clarify which food is “authentic” or better 
still “halal” and ensure accurate labelling in order to protect muslim consumers as 
well as promote fair trade (JAKIM, 2013). 
 
1.2.3 Drug Information Definition and Background 
 
Drug information is an area of pharmacy practice that deals with obtaining, 
managing, and evaluating information to prepare and disseminate it in a suitable 
format, wherever and whenever it is needed or in anticipation of need (DiPiro, 2003). 
The drug information specialist has not specifically been considered a documentation 
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specialist, as is a librarian, but was originally defined as a subject-oriented specialist 
in the area of drug knowledge (Francke, 1966). 
 
Drug information is one of the early fields in clinical pharmacy. Drug 
information centres were established in the mid of 1960s.  The decision to establish a 
drug information centre was made in 1959 at Ohio State University and 1960 at the 
University of Kentucky, with the latter one was the first to open in 1962 (Amerson & 
Wallingford, 1983). Pharmacists who work in drug information review, collect, 
organize, and analyze drug information and spread it to health-care professionals and 
consumers (Gong, Millares, & VanRiper, 1992).   
 
Drug information centres  and services work now in different fields such as 
pharmaceutical industry, health-care institutions, academic settings and universities, 
usually as functioning departments within the organization (Justice, 1993). Some 
centres work as independent centres especially with economic benefits from drug 
information software and internet services for health-care professionals and the 
public (Russello & Peterson, 1993). The activities of drug information centres or 
services have increased dramatically since they were first established. Usually 
health-care practitioners refers to drug information centres or services when 
assistance is required in handling a difficult clinical problem or when significant time 
or resource constraints exist (poison centres for example). Table 1.2 summarizes the 
medication information services provided by different drug information centres. 
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Table 1.2: Medication information services, (adapted from (Malone, Kier, & 
Stanovich, 2011) 
 
Support for clinical services 
Answering questions 
Developing criteria/guidelines for medication use 
Pharmacy and therapeutics committee activity 
Development of medication use policies 
Formulary management 
Publications—newsletter, journal columns, websites 
Education—in-services for health professionals, students, consumers 
Medication usage evaluation/medication use evaluation 
Investigational medication control 
Institutional Review Board activities 
Information for practitioners 
Coordination of reporting programs, e.g., adverse medication reactions 
Poison information 
 
 
Pharmacists working in the area of drug information should have some of the 
skills of a documentation specialist because these skills are necessary to manage 
information. The difference between drug information specialist and documentation 
specialists is that the drug information practitioner has the ability to adequately 
understand the initial problem and after locating the information can evaluate the 
information to formulate a solution to a particular pharmacy or medication-related 
issue. Because of this ability, drug information practitioners have occasionally been 
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referred to as the "ultimate generalist" in pharmacy (DiPiro, 2003). The drug 
information practitioner has the in depth knowledge of how to obtain the necessary 
information and use it to address specific problems or concerns in most areas.  
 
The need for drug information practitioners is increased due to the rapid 
increases and improvements in information and the technology to manage it, 
particularly due to internet technology and information sources which produce 
millions of new articles and research every year. Finding information is only small 
part of the skills needed for drug information specialist and should have greater skills 
to handle larger and more complex information management situations (Malone et 
al., 2011). Table1.3 summarizes the skills needed for drug information specialist. 
 
Table 1.3: Medication information skills, (adapted from (Malone et al., 2011) 
 
Assess available information and gather situational data needed to characterize 
question or issue 
Formulate appropriate question(s) 
Use a systematic approach to find needed information 
Evaluate information critically for validity and applicability 
Develop, organize, and summarize response for question or issue 
Communicate clearly when speaking or writing, considering the audience level 
Anticipate other information needs 
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Several factors play an important role in the evolution of the pharmacist’s 
role as a medication information provider. These include the prevention of adverse 
drug events, the sophistication of medication therapy, the rapid growth of 
information technology due to the advance in computer and internet sciences, 
depending on the evidence-based medicine which focus on the evaluation of 
outcomes and finally the change in the patient personality who become a more 
knowledgeable patient (Hunt, Haynes, Hanna, & Smith, 1998). 
 
Usually the term drug information is coupled with terms such as specialist, 
centre, or service. Some people use the words medication or biomedical instead of 
drug due to the negative connotation that the drug term has in society (Hunt et al., 
1998). Some writers used the word informatics instead of information, to better 
acknowledge the increased role of computers in information management. Pharmacy 
or Medical Informatics is different than drug information now and it is more focus on 
the computer and programming side than the clinical pharmacy side (Shortliffe & 
Blois, 2006). Medical informatics has been defined as the rapidly developing science 
that deals with the storage, retrieval, and optimal use of biomedical information, 
data, and knowledge for problem-solving and decision-making (Allen, 2012). 
 
 Drug information or medication information is a term that indicates that 
people working in this area deal with information relating both to drugs (e.g., 
therapeutics, adverse drug reactions) and to pharmacy (e.g., how to perform various 
pharmacy tasks) this term is broadened to include both pharmaceutical and 
therapeutic knowledge (DiPiro, 2003). 
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Receiving question or the problem 
•understand the question and identify the genuine 
need 
•check the question list which should considered 
before starting the research 
   Searching for information.  
•Know the variety of information resources available 
•Know how and why to use each resource 
•Selecting the proper database  
•Selecting the proper search strategy  
Sorting out the information   
•The current information not the dated 
•The reliable information not the questionable 
•The actual information not the imagined 
Analyzing the information to make decision 
•Analyzing the clinical drug literature  
•Evaluating the clinical drug literature  
•Interpreting the clinical drug literature  
•Get the final decision 
Formulating the response or the answer 
•check the factors that should consider during 
formulating the response 
•the response should be timely, current, accurate and 
complete 
A primary role of the pharmacist as a pharmaceutical care provider is to 
respond to drug information questions from other health-care professionals and 
patients and to help resolve drug therapy related problems. Pharmacists must also be 
able to assist patients in meeting their information needs with regard to drugs, 
therapies, and diseases (Malone et al., 2011). Figure 1.1 illustrate the basic logical 
steps to formulate answer or response regard any drug information question since 
receiving the question and until the formulating of the response or the answer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Illustration of the basic steps in response to medication information request. 
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There are many types of drug information needed by practicing pharmacists 
and other health-care professionals they are varied and include, but are not limited to:  
1. Information about side / adverse effects,  
2. Drug interactions,  
3. Uses,  
4. Teratogenicity,  
5. Stability, and compatibility, 
6. Product identification   
7. Availability,  
8. Dosages and administration,   
9. Toxicity,   
10. Pharmacokinetics,  
11. Pharmacodynamics,  
12. Pharmacogenomics,  
13. Health-related quality of life, 
14. Pharmacoeconomics; and  
15. Efficacy, which include the comparative efficacy among  
16. Drugs in the same chemical or pharmacological class  
17. Drugs from different classes.  
 
1.2.4 Halal Pharmaceuticals Systematic Literature Review 
 
Systematic review resulted in the availability of 673 articles. Of these, 42 
articles were excluded because the language of literature was other than English 
(Arabic, Malay Urdu & French), 146 being magazine articles (non-peer reviewed), 
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273 being conference proceedings and remaining were excluded because they were 
solely on halal food and not halal pharmaceuticals. Table 1.4 presents the summary 
of articles that matched all inclusion and exclusion criteria of this study and were 
included in this study. 
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Table 1.4: Systematic review of halal pharmaceuticals peer reviewed articles 
 Title  of Article Author Year  Journal Summary  and Comment 
1 Applying Islamic Principles of Halal 
and Haram to the Field of 
Pharmaceutical Sciences 
 
(Iqbal, Saeed, Nasir, & Khuda, 2011) 
zaki ullah,  
Zafar Iqbal, 
Muhammad 
Saeed,  
Fazli Nasir,  
Fazli Khuda,  
Abuzar khan 
2011 PUTAJ 
SCIENCES 
This article provides a comprehensive list of haram 
pharmaceutical ingrediants and their therapeutic uses 
 
The article discusses diseases and available 
treatments in the light of Quran and Sunnah. This 
focus is more on the use of alcohol and gelatine for 
medicinal purposes.  
 
 
2 Assessment of knowledge, attitude & 
perception among hospital 
pharmacists regarding Halal 
pharmaceuticals 
 
(Sadeeqa & Sarriff, 2014) 
Saleha Sadeeqa,  
Azmi Sarriff 
2014 Journal of 
Applied 
Pharmaceutical 
Science 
A cross-sectional study, to measure knowledge, 
attitude and perception (KAP) of halal 
pharmaceuticals. A total of 135 pharmacists from 
January 2013 to March 2013 were included in this 
structured, self-administered questionnaire study. 
Results revealed that the hospital pharmacists had a 
good knowledge and positive attitude and perception 
about Halal pharmaceuticals. 
 
This article elaborates general perceptions of halal 
pharmaceuticals and does not assess KAP of any 
specific pharmaceutical. 
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 Title  of Article Author Year  Journal Summary  and Comment 
3 Development of clay liquid detergent 
for Islamic cleansing and the stability 
study 
 
(Angkatavanich, Dahlan, Nimmannit, 
Sriprasert, & Sulongkood, 2009) 
J. Angkatavanich, 
W. Dahlan,  
U. Nimmannit,  
V. Sriprasert, 
N. Sulongkood 
2009 International 
Journal of 
Cosmetic 
Science 
Clay liquid detergents (CLDs) were developed for 
cleansing religiously-prohibited dirt (‘najis’) 
according to Islamic law. Four types of clay were 
selected: marl, kaolin, bentonite and veegum. After 
product development trials, five CLD formulations 
with varying combinations of clays were qualified 
for stability testing. F2 (kaolin-based, with a white, 
creamy texture) was the best CLD formula. It had 
the highest surface activity, moderate lathering and 
pleasant physical appearance. 
 
This is the only invention related to halal 
pharmaceuticals, all porcine detection kits were for 
food use only. Now there are five companies 
produced CLD formulations. 
 
4 Evaluation of knowledge, attitude, and 
perception regarding Halal 
pharmaceuticals, among general 
medical practitioners in Malaysia 
 
(Sadeeqa, Sarriff, Masood, Farooqi, & 
Atif, 2013) 
 
Saleha Sadeeqa, 
Azmi Sarriff, 
Imran Masood, 
Maryam Farooqi, 
Muhammad Atif 
2013 Archives of 
Pharmacy 
Practice 
A cross‑sectional study, to evaluate KAP with 
general medical practitioners (from Sep 2012 - Nov 
2012), using a structured, self‑administered 
questionnaire.  Results revealed that general medical 
practitioners in Malaysia have a good knowledge 
and positive attitude and perception towards Halal 
pharmaceuticals. 
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 Title  of Article Author Year  Journal Summary  and Comment 
5 Exploring the Halal Status of 
Cardiovascular, Endocrine, and 
Respiratory Group of Medications 
 
(Sarriff, 2013) 
 
 
Azmi Sarriff,  
Hadeer Akram 
Abdul razzaq 
2012 Malaysian 
Journal of 
Medical 
Sciences 
Study aims to determine the Halal status of selected 
cardiovascular, endocrine, and respiratory 
medications stored in an out-patient pharmacy in a 
The proportions of Halal, Mashbooh, and Haram 
products were at 19.1%, 57.1%, and 23.8%, 
respectively.  
Ethanol and magnesium stearate were found to be 
the common substances that were categorized as 
Haram and Mashbooh. 
Thisstudy depends on the information obtained from 
the  leafinserts and from MIMS to know the contents 
of the drugs.  
This study focuses on highlighting the trade names 
and formulations instead of describing the origin of 
the active ingredients. 
This study considers ethanol of all origins as haram 
for use in pharmaceuticals and does not specifically 
take into account the synthetic/denatured ethanol. 
 
6 Factors associated with uptake of 
vaccination against pandemic 
influenza: A systematic review 
 
(Bish, Yardley, Nicoll, & Michie, 
2011) 
Alison Bish,  
Lucy Yardley, 
Angus Nicoll, 
Susan Michie 
2011 Vaccine Study aims to examine the psychological and 
demographic factors associated with uptake of 
influenza vaccination during the 2009 pandemic. By 
making a systematic literature review searching Web 
of Science and Pub Med databases up to January 
2011. 
 
This research paper refers to a Malaysian study 
which emphasizes the need of halal vaccines. 
 
 
 
 14 
 
 Title  of Article Author Year  Journal Summary  and Comment 
7 Fish gelatine and its applications in 
selected pharmaceutical aspects as 
alternative source to pork gelatine 
 
(Elgadir, Mirghani, & Adam, 2013) 
M. Abd Elgadir,  
Mohamed 
Mirghani, 
Aishah Adam 
2013 Journal of 
Food, 
Agriculture 
and 
Environment 
This review summarizes gelatine in four areas: (1) 
pig gelatine and halal issue, (3) selected methods 
used in fish gelatine extraction, (3) selected 
functional properties of fish gelatine and (4) selected 
pharmaceutical and medical application of fish 
gelatine 
 
 
 
8 Fish Gelatine: A Versatile Ingredient 
for the Food and Pharmaceutical 
Industries 
Book chapter in 
Marine Proteins and Peptides: 
Biological Activities and Applications 
 
(Gudipati, 2013) 
Se-Kwon Kim, 
Venkateshwarlu 
Gudipati 
2013 Book chapter  Mention fish gelatine sources, extraction method, 
properties, and challenges. The most important 
challenges of fish gelatine are its fishy odour and 
poor rheological properties, limiting its utility to a 
few products. Development of improved processes 
for eliminating the odour and enhancing the 
desirable functional and rheological properties by 
incorporating co-enhancers would certainly make 
fish gelatine a versatile ingredient for both the food 
and the pharmaceutical industry. 
 
 
9 Halal market surveillance of soft and 
hard gel capsules in pharmaceutical 
products using PCR and southern-
hybridization on the biochip analysis 
 
(Sahilah, Norrakiah, Aminah, Wan 
Aida, & Ma'aruf, 2012) 
Sahilah, A. M., 
Mohd. Fadly, L.,  
Norrakiah, A. S.  
Aminah, A., 
Wan Aida, W. M. 
Ma’aruf, A. G  
Mohd. Khan, 
2012 International 
Food Research 
Journal 
The study was conducted to detect the porcine DNA 
in pharmaceutical products in local market using 
polymerase chain reaction (PCR) and southern-
hybridization on the biochip. Of all samples tested, 
37.2% (42/113) contained porcine DNA. 
 
Other researches published in conferences (not in 
journals) regard the use of different analytical tools 
for fast porcine detection. 
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 Title  of Article Author Year  Journal Summary  and Comment 
10 Halal Nutraceutical Market: Issues 
and Challenges 
 
(Ehsan, 2008) 
Zhari Ismail,  
Abdul Halim 
Ehsan 
2010 SEGi Review The article studies the following issues: sourcing, 
handling, processing, manufacturing, labelling, 
control and registration of the products. The article is 
good source to gather different challenges which 
may face worker in this field like: standardizing 
procedures and generating acceptable parameter 
standards. 
11 Immunisation and informed decision-
making amongst Islamic primary 
school parents and staff 
 
(Bray & Keating, 2012) 
Matthew Bray, 
Daniel Keating 
2012 Australian 
Medical 
Student 
Journal 
This study aims to evaluate the information and 
knowledge with which Islamic parents and staff are 
equipped to make decisions about immunisation. 
40.7% (n = 64) of respondents were not confident 
that they knew enough about vaccines to make good 
decisions, while 73.3% (n=115) respondents stated a 
personal desire for further education about 
vaccinations and vaccination schedules. 
 
The study highlight the low knowledge about 
vaccines and how it made among non professionals, 
at the same time it highlight the increased awareness 
in the Muslim community regard the halal 
pharmaceuticals. 
 
12 Investigation into the suitability and 
accessibility of catering practices to 
inpatients from minority ethnic groups 
in Brent 
 
(Hartley & Hamid, 2002) 
B. A. Hartley, 
F. Hamid 
2002 Journal of 
Human 
Nutrition and 
Dietetics 
Study aims to review accessibility and suitability of 
multicultural meals to minority ethnic communities 
across five hospital sites in Brent and determine the 
level of nursing staff knowledge of multicultural 
dietary competencies. 
 
The study highlights the importance of providing 
halal meals for patient in hospitals and how to 
measure the patient satisfaction. 
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 Title  of Article Author Year  Journal Summary  and Comment 
13 Islamic Verdicts in Health Policy 
Discourse: Porcine-Based Vaccines as 
a Case Study 
 
(Padela, 2013) 
Aasim I. Padela 2013 Zygon Journal 
of Religion 
and Science 
Study analysis the opinion of scholars from using 
porcine-based vaccine by studying in details the 
IOMS opinion and the MUI. Researcher tries to 
highlight the importance of the istihalah concept. 
 
The study is one of other conference papers and 
newspaper articles which try to make using pig 
product halal without studying the in depth of 
Islamic issues. 
14 Knowledge, attitude and perception 
regarding Halal Pharmaceuticals, 
among academicians in various 
universities of Malaysia 
 
(Saleha Sadeeqa, Azmi Sarriff, Imran 
Masood, & Farooqui, 2013) 
Saleha Sadeeqa, 
Azmi Sarriff, 
Imran Masood 
Maryam Farooqui 
2013 International 
Journal of 
Educational 
Research and 
Development 
This is a cross-sectional study, carried out between 
November 2012 and December 2012, using 
structured, self-administered questionnaires to 
evaluate the Knowledge, Attitude and Perception 
(KAP) regarding Halal pharmaceuticals, among 
academicians in various universities of Malaysia. 
The study was conducted on a sample of 170. 
Results show good KAP with positive attitude and 
fair correlation. 
 
 
15 Knowledge, Attitude and Perception 
Regarding Halal Pharmaceuticals 
among General Public in Malaysia 
 
(Sadeeqa, Sarrif, Masood, Saleem, & 
Atif, 2013) 
Saleha Sadeeqa, 
Azmi Sarriff, 
Imran Masood, 
Fahad Saleem, 
Muhammad Atif 
2013 International 
Journal of 
Public Health 
Science 
(IJPHS) 
A cross sectional, self administered questionnaire 
based study that assessed knowledge, attitude & 
perception of general public of Penang, Malaysia 
regarding Halal pharmaceuticals, Study population 
of 458 Muslims, revealed that public has a good and 
positive attitude towards Halal pharmaceuticals 
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 Title  of Article Author Year  Journal Summary  and Comment 
16 New Technology for Preparation of 
Herbal Extracts and Soft Halal 
Capsules on its Base  
 
(Shikov, Pozharitskaya, Makarov, & 
Makarova, 2009) 
Alexander 
Shikov,  
OlgaPozharitskay
a,  
Valery G. 
Makarov, Marina 
N. Makarova 
2009 American-
Eurasian 
Journal of 
Sustainable 
Agriculture 
Original technology for halal soft capsules with 
herbal oil extracts was developed. Agar 
polysaccharides from Gracilaria species 
(Rhodophyta, Gracilariaceae) is used for formulation 
of soft capsules instead gelatine. 
 
17 Novel Computerized Halal 
Pharmaceuticals Supply Chain 
Framework for Warehouse and 
Procurement 
 
(binti Raja, bin Abdul, & Hasan, 
2013) 
Raja Rina binti 
Raja Ikram, 
Mohd Khanapi 
bin Abdul Ghani, 
Abdul Samad 
Hasan Basari 
2013 International 
Journal of 
Computer 
Applications 
The paper proposes a framework to manage the halal 
supply chain when computerized systems are being 
used for the warehouse and procurement module. 
The proposed framework is the outcome of a case 
study of a Malaysian pharmaceutical organization, 
Pharmaniaga Manufacturing Berhad in Bangi, 
Selangor. 
 
The only article regard computer applications in 
halal pharmaceuticals, there are few conference 
proceedings which deal with the same idea. 
 
18 Parental refusal to diphtheria vaccine: 
a fatal outcome 
 
(Syafinaz et al., 2013) 
Syafinaz Amin N;  
Faridah I;  
Rukman AH;  
Fathinul Fakri 
AS;  
Malina O;  
Fadzillah G;  
Ilina I;  
2013 The Medical 
Journal Of 
Malaysia 
A case of a four-year-old boy who succumbed to 
diphtheria following incomplete course of 
immunisation, which included diphtheria vaccine. 
This case report focuses on the issues of parental 
refusal to vaccines and the development of "halal" 
vaccines for the prevention of infectious diseases. 
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 Title  of Article Author Year  Journal Summary  and Comment 
19 Production of Halal Herbal Medicinal 
Products in Chanae Hospital: a 
Community Hospital in Narathiwas 
Province, Thailand 
 
(Chaowalit Monton, Krisana 
Kraisintu, & Chankana, 2013) 
Chaowalit 
Monton, 
Krisana Kraisintu, 
Natawat 
Chankana 
2013 Thai Journal of 
Pharmaceutical 
Sciences 
Article tells how the cooperation between an 
academic institute (Rangsit University) and 
community hospital (Chanae Hospital) can promote 
the production of herbal medicinal products. The 
mini-plant was set-up on the border of Thailand in 
an area of unrest, and five items of gamma irradiated 
herbal products have been produced following halal 
authentication. 
 
20 Religious Values and Healthcare 
Accommodations: Voices from the 
American Muslim Community 
 
(Padela, Gunter, Killawi, & Heisler, 
2012) 
Aasim I. Padela,  
Katie Gunter, 
Amal Killawi, 
Michele Heisler 
2012 Journal of 
General 
Internal 
Medicine 
Participants reported and identified three key 
healthcare accommodations to address Muslim 
sensitivities: the provision of (1) gender concordant 
care, (2) halal food and (3) a neutral prayer space. 
Halal food was deemed to be health-promoting and 
therefore integral to the healing process.  
 
21 Vaccine Manufacturing in Islamic 
Perspective 
(Mel & Ja'afar, 2009) 
Maizirwan Mel, 
Ja'afar Nuhu 
Ja'afar 
2009 Ethics of 
Engineering 
Education 
The article deals more with the ethics and the 
concept of vaccination in Islam rather than setting 
the halal rules to manufacture the vaccine. 
 
22 What the World’s religions teach, 
applied to vaccines and immune 
globulins 
 
(Grabenstein, 2013) 
John D. 
Grabenstein 
2013 Vaccine This paper reviews the populous faith traditions 
including Hinduism, Buddhism, Jainism, Judaism, 
Christianity, and Islam. Subjects of concern such as 
blood components, pharmaceutical excipients of 
porcine or bovine origin, rubella strain RA 27/3, and 
cell-culture media with remote foetal origins are 
evaluated against the religious concerns identified. 
 
Informative review to understand other religions 
opinion regard vaccine, at the same time it doesn’t 
set all rules to manufacture the halal vaccine. 
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 Title  of Article Author Year  Journal Summary  and Comment 
23 Young multiethnic women's attitudes 
toward the HPV vaccine and HPV 
vaccination 
 
(Wong, 2008) 
Li Ping Wong 2008 International 
Journal of 
Gynaecology 
and Obstetrics 
To investigate the acceptability of the HPV vaccine 
among a multiethnic sample of young women in 
Malaysia. Concerns were raised regarding the 
vaccine's safety, and whether the vaccine was halal. 
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1.2.5 Halal Pharmaceuticals Current Situation  
 
Muslims concern about the source of medicine and the halalness of its 
component begins from the beginning of Islam message. Many hadith books (books 
that contain the Sunnah of the prophet) contain special chapters called medicine 
chapter; these chapters include the prophet instructions regarding health and 
prohibited materials in medicine and also the materia medica which prescribed or 
used by the prophet.  
 
Medicines in Arabia were simples and the main prohibited material was using 
the Khamar in medicine (alcoholic drinks). Using different parts from animals start 
to get into the Islamic civilization from the interaction with the Roman’s materia 
medica. Muslims scholars started to study the opinion of use these parts from dead, 
makrooh and prohibited animals and produce different fatwa about this new issues to 
Islamic fiqh. Muslim pharmacists start search for alternatives for the suspected and 
prohibited materials; which lead them to replace or substitute these materials this 
help in improving the compounding techniques which improve pharmacy in general 
(Al-Fakii, 1995).  
 
Due to the development in pharmacy many biological medicines are 
introduced and the majority of these drugs or excipients are not halal. The truth that 
all biological and the majority of active ingredients are made in non Islamic 
countries. These countries do not know and or have no regard on the halalness of the 
medicines (IOMS, 1995). The concern about halal medicines and pharmaceuticals 
are still in the beginning stage comparing to the food sector.  
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To the best of our knowledge, the first standard guideline for halal 
pharmaceuticals MS2424/ 2010 has been published in February 2011 in Malaysia 
(SIRIM, 2010). Prior to this a guideline of such standards was published in Brunei 
Darussalam that focussed the terms of reference for halal pharmaceuticals. The 
MS2424/2010 was revised in October 2012 as a more comprehensive version; 
MS2424/ 2012. It has been described as the first halal ecosystem for halal 
pharmaceuticals in the world (“HDC,” 2013). 
 
There is a great need to scientifically and more systematically assess different 
sectors of halal industry, especially the halal pharmaceuticals. Halal index (Ihsan & 
Ismail, 2011) is the first and  only book published until now in this field. Plans to 
expand these reference works by the cooperation between HDC (Halal industry 
Development Corporation) and different Malaysian bodies and universities are 
underway. This plan includes producing the official guidelines for halal fatwa 
(JAKIM, PPUM), halal pharmacopoeia (USM), product specific halal standards 
(UPM), and halal professional auditing manual (USIM). 
 
The concerns regarding halal pharmaceuticals are increasing among 
consumers and patients, which require more efforts from doctors, and pharmacists to 
answer patient’s questions with regard to halal pharmaceuticals (Ismail & Ehsan, 
2010). Producing different scientific reference materials suitable for doctors, 
pharmacists, health care providers, and factory workers will be a great service to 
more than one billion Muslim around the world (Ramli, Salleh, & Azmi, 2012). 
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This research will try to get the real size of the problem (by gathering 
information regard the real size of the haram and doubtful materials among 
pharmaceuticals). The problems related to halal pharmaceuticals have been well 
discussed, however, this thesis will propose standard operating procedures (SOPs) 
for factories, designing plan of halal pharmaceutical manufacturing and the need to 
write a halal pharmacopeia. 
 
It is therefore important to prepare a comprehensive list which categorizes all 
pharmaceuticals according to their origin. This list may comprise of the red list that 
contains the haram pharmaceuticals, produced from prohibited sources, the grey list 
containing suspected pharmaceuticals which may be produced from both halal or 
haram sources and the green list containing pharmaceuticals from halal sources. This 
study uses drug information system methods and techniques to achieve the research 
objectives more accurately, effectively and timely. This will set the ground work 
based on which a halal pharmacopeia can be written. 
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1.3 Objectives and Scope of Research 
 
The general objectives of this study are to:   
1. To elucidate fiqh (Jurisprudence) for pharmaceuticals as espoused in Islamic 
teachings and its application to the current pharmaceutical context. (Chapter 
2). 
2. To gather and elucidate the issues related to halal pharmaceuticals (Chapter 
3). 
3. To formulate halal pharmaceuticals SOPs for worker in factories and drug 
production. (Chapter 4) 
4. To propose and formulate the halal pharmacopoeia writing plan, which 
includes the drug information resources needed, examples for the 
comprehensive lists of natural and animal derived pharmaceutical substances, 
and model drugs monographs. (Chapter 5) 
Action plan for this study was as follows:  
1. The thesis written and organized according to the objectives; each chapter in 
the thesis study and discuss one of the objectives mentioned above. 
2. Each chapter study and discuss one topic by setting the chapter objectives, 
methods and information report (which take the place of results in the 
experimental fields).  
3. The information report will contain the current situation of the topic; it is 
main information resources, and how to use these resources to answer 
different questions from consumers or professionals. 
4. All supporting documents, lists and bibliographies which help researchers in 
this field organized at the appendix. 
